DIAGNOSE 3 -
Tränen-FILM STABILITÄT (Break-Up Time - BUT / Tränenfilm Aufbruchszeit - TAZ)
Die Tränenfilm Aufbruchszeit (BUT) ist einer der wichtigsten funktionellen Werte für die Intaktheit und Gesundheit der Augenoberfläche. Die beschreibt die Zeit in Sekunden, in der der Tränenfilm intakt bleibt bis zu seinem ersten Aufbruch an irgendeiner Stelle.
Sobald der Tränenfilm aufbricht beginnen die empfindlichen Zellen der Augenoberfläche sofort auszutrocknen, Schaden zu nehmen und entsprechend das Gefühl von Irritation oder sogar Schmerz über die Nervenfasern an das Gehirn zu senden … was dann entsprechende Beschwerden des Patienten auslöst.
Wie in den Kapiteln über die ´Augenoberfläche´ and ´Tränen und Tränenfilm´ beschrieben wird, ist ein intakter Tränenfilm eine Grundvoraussetzung für die Gesundheit der Augenoberfläche und auch für eine perfekte Sehschärfe.
Üblicherweise wird die Stabilität des Tränenfilms geprüft durch die Gabe des Vitalfarbstoffs Fluoreszein für den sogenannten FLUO-BUT Test. Der Fluoreszenzfarbstoff dient dazu die Oberfläche des Tränenfilms ausreichend sichtbar zu machen an der Spaltlampe.
Fluoreszein wird typischerweise als kleines Tröpfchen aus einer Flasche gegeben, so dass dieser Test einfach und einigermassen wiederholbar und zuverlässig ist.
Abgesehen davon. dass der das Objekt des Interesses, der Tränenfilm, durch die Zugabe von Fluoreszein bereits verändert wird, ist dieser Test nur dann einigermassen zuverlässig, wenn möglichst einige Bedingungen konstant gehalten werden:
die Menge von Flüssigkeit, die in den Tränenfilm gegeben wird
die Konzentration von Fluorescein
Beides kann leicht variieren, abhängig von der Menge von Tränen, die bereits auf der Augenoberfläche sind.
Ein kleiner Nachteil ist, dass einige Patienten nicht unbedingt begeistert sind von der Anwendung von Fluoreszein, da dies ein sehr intensiver Farbstoff ist, der die Lidränder noch für eine Weile anfärben kann ... und das Make-up ruinieren mag ... aber was ist das schon im Vergleich zur grossen Nützlichkeit dieses Tests.
Da die Zugabe von Fluoreszei-Tropfens den Tränenfilm bereits verändert wird faktisch nicht die ´wahre´ Aufbruchszeit gemessen, sondern eine ´künstliche Aufbruchszeit´. Wenn der Test aber standardisiert, immer hinreichend gleich, durchgeführt wird, sind die Ergebnisse recht zuverlässig und es verbleibt nur ein kleiner systematischer Fehler. Daher hat der FBUT Test in den letzten Jahrzehnten viele wertvolle Ergebniss zur Augenoberfläche und dem Trockenen Auge erbracht.
BUT - NON-Invasive (NI-BUT)
NON-Invasive BUT (NI-BUT) offers all the advantages that are missing in the conventional Fluo-BUT.
It requires, however, a special equipment that allows monitoring of the tear film lipid layer by interferometry and therefore allows to see a disruption of the tear film without any additional staining or other modification of the tear film.
The necessary equipment is typically a TOPOGRAPHER as already described above for the monitoring of lid and blinking dysfunction (LBD). The necessity of a topographer is no major disadvantage because these very versatile machines are anyway almost indispensable for an up-to-date Ocular Surface and Dry Eye Specialist.
Tear film stability in NI-BUT is longer than in F-BUT
As can be assumed, a totally unaltered tear film has a different break-up time, as evaluated in NI-BUT, compared to a tear film that is already altered by addition of an aqueous solution including a staining substance, which is typically fluorescein (F-BUT).
Indeed the measured NI-BUT is typically longer than the respective F-BUT in the same patient.
NI-BUT therefore has different normal values compared to the conventional F-BUT and this must be kept in mind when BUT values in different patients are compared that were probably made with different techniques or when different BUT values in the same patient are compared over time that were probably evaluated with different techniques.
Tear FILM LIPID LAYER Analysis
The tear film lipid layer (TFLL) is the superficial phase of the Three-Layered tear film
The superficial layer or phase of the tear film is composed of LIPIDS that have, according to the present knowledge, mainly the function to retard the evaporation of the underlying aqueous main phase of the tears. It may also contribute to other functions such as e.g. to aid in spreading of the tears into a thin film.
The aqueous phase from the main and accessory lacrimal glands is towards the underlying epithelium conceivably increasingly mixed with secreted gel-forming mucins from the goblet cells.
Altogether this leads to the present concept of the tear film as a more or less three-layered structure which dates back basically to the times of Eugene WOLFF who explained this concept in 1946 ... in a time when probably not too many people were too much interested in such questions.
The TFLL has two Sub-Layers with different characteristics
The lipid layer is very thin ... in the area of about 100 nanometers (nm) - which is only approximately 10 times the thickness of a cell membrane. Still it appears to be composed of two sub-layers.
The outside thicker sub-layer is composed of non-polar hydrophobic lipids
The outside thicker sub-layer appears composed of non-polar and thus hydrophobic lipidsThe outside thicker sub-layer appears composed of non-polar and thus hydrophobic lipids which leads to the problem, or should we better say challenge (?), that these lipids cannot bind to the underlying water in order to be held in place and to form a sufficiently homogeneous layer, that is necessary for perfect refraction of the incoming light and thus for a sharp vision ... or perfect visual acuity.
The inside layer has polar lipids to maintain connecTion with the aqueous subphase
Therefore, an inside connecting layer of lipids is necessary that can bind to its lipid mates at the surface but also to the underlying water. There are also some candidate proteins that may help in this function of binding hydrophobic lipids to an underlying water phase.
Die Dicke der ÖLSCHICHT auf dem Tränenfilm kann gemessen werden durch die Analyse der Interferenzfarben (INTERFEROMETRIE)
Die Analyse der Menge der Lipide im Tränenfilm ist, unter der Annahme, dass sie eine einigermassen homogene Ölschicht an der Oberfläche bilden, möglich durch die Messung der Dicke dieses Lipidfilms.
Die Dicke der Lipidschicht wiederum lässt sich durch die Messung der Interferenzfarben bestimmen. Dies sind ´Falschfarben´ ähnlich den schillernden Farben eines Ölflecks auf einer Wasserlache oder den Farben an der Oberfläche einer Seifenblase. Diese Farben stehen in direkter Beziehung zur Dicke der Ölschicht, die sehr dünn ist und in einem Bereich um etwa 100 Nanometer, also ein Zehntausendstel Millimeter liegt.
Die Messung der Dicke der Lipidschicht ist daher glücklicherweise einfacher als die Bestimmung der Dicke des gesamten Tränenfilms, über die in der Vergangenheit sehr unterschiedliche Werte ermittelt wurden und die bis heute nicht ganz klar ist.
Unter geeigneter Beleuchtung produzieren Schichten im Dickenbereich um 100 Nanometer Interferenzfarben die von grau (sehr dünn) über silber und blau bis zu gelb und rot (sehr dick) reichen.
INTERFEROMETRIE in der klinischen Praxis - der Gold-Standards der Lipid-Schicht Analyse des Tränenfilms
In theory is is possible to make the interference colors of the TFLL visible with an ordinary slit-lamp when the illumination is manually adapted in order to produce sufficient stray light to be able to see a glimpse of what the interference may look like ... but this procedure is typically not very exact and not very satisfying.
Two excellent interferometers were developed by clinical specialists
The first practically usable device appears to be the TearScope (produced by Keeler Inc.). This is a hand-held device that was developed by Jean-Pierre GUILLON in the mid 1980s and introduced at the legendary Lubbock, Texas, Tear Film & Dry Eye Congress in 1984.
The Tear Scope allows to study the tear film and its lipid layer in much detail. Some years later a improved TearScope ´Plus´ version was developed.
The general interest in the tear film lipid layer was however limited during that time and later so that too few instruments were sold world-wide and later the production was stopped.
With the advent of increased interest in Meibomian Gland Dysfunction (MGD) and Tear Film LIPIDS a new ´ADVANCED TearScope´ became available.
This is up-to-date and thus allows to connect to a mobile tablet computer in order to record and document the obtained data which is certainly of advantage for a seamless integration into the clinical workflow.
Another interferometer was about 20 years later also developed by a dedicated clinical specialist for the Tear Film Lipid Layer - this was Donald KORB. Korb and colleagues developed the instrument in the clinical practice according to the practical needs of the clinician.
The goal was to develop an instrument that reveals the highest standards of imaging quality in order to achieve the greatest exactness in measurement combined with best convenience in usage and documentations of results in order to fit in seamlessly into the practical clinical schedule. This device was later produced by the company TearScience under the name Lipiview.
In addition, this machine can also perform Meibography with immaculate perfection as will be discussed in the chapter for Meibography.
The Lipiview automatically records the tear film lipid layer over a wide field of view in a movie, records the eye blinks including partial blinks and performs fully automated analysis of the data that can be printed out in a report (please see image).
Legend: The interferometric image of the tear film lipid layer, produced here with the TearScience Lipiview, shows that a tear film with normal thickness has a mixture of interference colors that are mainly reddish-golden (upper image). This is equivalent to an average thickness of 90 nanometers. The lipid layer in the lower image is too narrow as can be detected by the grey interference ´color´ - the automatic measurement reveals an average thickness of 35 nanometers.
Analysis of the Tear Film LIPID LAYER is an important component of a meaningful Dry Eye Investigation
The development of the Lipiview device fell into the period when it was eventually recognized that a deficiency of the Tear Film Lipids is the main causative factor for Dry Eye Disease in the vast majority of patients. This refers to about 4 out of 5 Dry Eye Patients who suffer from this primary cause and underlines that analysis of the tear film lipid layer represents and important and necessary component of a meaningful ocular surface investigation. The main reason for lipid deficiency, as evaluated by the TFOS MGD Report (freely available at: www.tearfilm.org) is the obstructive Dysfunction of the Meibomian Glands, termed Meibomian Gland Dysfunction, and mostly abbreviated as MGD).
Since the TFOS MGD Report in 2011, the interest in the Tear Film Lipid Layer (TFLL) has rightfully almost exploded which has lead to the development of several new and convenient devices for tear film and TFLL analysis. This development has made the important Diagnostics of Tear Film and TFLL available to every clinician who is concerned with the Ocular Surface.
Tear OSMOLARITY Evaluation
As we now know very well, the Osmolarity of the Tears may typically increase in that type of Dry Eye Disease that occurs due to a quantitative or qualitative deficiency of the tear film lipids. Lipid Deficiency occurs typically due toobstructive Meibomian Gland Dysfunction (MGD).
In lipid deficient conditions the evaporation-retarding effect of the tear film lipid layer is impaired to different degrees that depend on the severity of the causative MGD.
LIPID DEFICIENCY TYPICALLY INDUCES INCREASED AQUEOUS TEAR EVAPORATION
Increasing inability to retard the evaporation of the aqueous main phase of the tears leads to hyper-evaporation of the tear water and thus to increasing osmolarity of the remaining tear fluid.
The reason is, that only the tear water evaporates like the water steam from a boiling pot of soup ... which leaves the rest more and more concentrated and thus, in the case of soup, increasingly salty.
The tears also contain different salts and ions that accumulate when the tear water evaporates. In the tears are additionally several other molecules such as all sorts of functional and regulative proteins. The tear proteins are hydrophilic and thus also like to be associated with water and have a ´water-dragging´, colloid-osmotic effect.
These basics were first prominently recognized, experimentally tested and reported by Jeff GILBARD in the 1970s, who consequently suggested a hypo-osmolar tear supplementation therapy, i.e. tears that contain relatively more water and less salts than the normal tears, for the therapy of hyper-evaporative dry eye conditions ... of which we now know, that they in fact represent the by far most frequent (about four fifth of cases) cause of Dry Eye Disease.
HYPER-OSMOLAR TEARS REPRESENT AN INFLAMMATORY STIMULUS TO THE OCULAR SURFACE EPITHELIUM
When hyper-evaporation has concentrated the hydrophilic particles in the remaining tears this fluid (as shown in the image above), has an increased osmolarity (often termed hyper-osmolarity) that basically exerts a water-dragging force onto the underlying cells and thus sets them under hyper-osmolar stress. The cells react in the only way they have learned to react - they set up their basic protective answer, which is inflammation - as explained in the chapter for Inflammation, because hyper-osmolarity represents a ´danger signal´ for cells. Ocular surface cells that are exposed to hyper-osmolar stress, as occurs in Dry Eye Disease, produce and secrete inflammatory cytokines as an important inflammatory answer as once reported by Steven PFLUGFELDERS group. The inflammatory cytokines can accumulate in the micro-environment of the ocular surface when the stimulating pathology becomes chronic and can then mount a chronic inflammatory reaction ... which potentially brings us back again into the middle of Chronic Inflammatory Dry Eye Disease.
Increased cytokine levels lead to downstream activation of stromal cell types and of vascular endothelial cells with immigration of further leukocytes into the tissue and all the unhappy events that occur in chronic mucosal inflammation as described by members of the OSCB in their TFOS Maui 2002 article and in the Ocular Surface Article in 2005.
These events include, among a stimulation of lymphocytes of the specific immune system also the production and activation of protease enzymes such as MMP9, that destroy the tissue structure.
HYPER-OSMOLARITY IS AN IMPORTANT SECONDARY PATHOGENETIC FACTOR IN DRY EYE DISEASE
Even though hyper-osmolarity is certainly an important factor in the pathophysiology of Dry Eye Disease, it is however not a ´Primary´ Factor in the pathophysiology because elevated tear osmolarity always needs something else to occur prior in order to induce it - because the lacrimal gland does not produce primarily hyper-osmolar tears.
As explained above and in in the Holistic Dynamic Concept on the Pathophysiology of Dry Eye Disease and in the Hierarchy of Pathogenetic Factors of Dry Eye Disease, the typical primary pathology that leads to the secondary pathogenetic factor of hyper-osmolarity is a deficiency of tear film lipids. Lipid deficiency in turn, is typically caused by the Causative Factor of Meibomian Gland Dysfunction (MGD).
TEAR FILM OSMOLARITY CAN BE AN IMPORTANT INDICATOR FOR DRY EYE DISEASE
After the initial recognition of the importance of a deficiency of tear lipids due to meibomian gland obstruction for Dry Eye Disease, which was reported even before the term ´Meibomian Gland Dysfunction´(MGD) was coined in 1980 by KORB and HERNANDEZ, Hyper-osmolarity had later enjoyed only a limited interest in the following years and was almost ´clinically dead´ by the end of the century.
In the mid to end of the first millennium decade osmolariy was re-discovered and was soon proposed as a new ´gold standard´ for diagnostics of Dry Eye Disease. This may have been related to the previous problems to measure osmolarity which was only possible with large and heavy instruments that were difficult to use and only available in an advanced laboratory setting.
This has changed a lot with the invention of a little, handy and easy to use automated instrument (TearLab) that is nowadays available to measure tear osmolarity very quickly and reliable in the clinical setting, directly besides the patient.
THE TEARLAB ALLOWS OSMOMETRY IN THE CLINICAL SETTING
The normal tear osmolarity is around or just under 300mOsm/l (milliosmol per liter) and undulates about plus/minus 10mosm around 298 mOsm/l. For orientation, the osmolarity of other body fluids is, e.g 275-320mOsm/kg or very similar for blood plasm and higher, i.e. > 400-500mos/l for urine.
Investigations with the TearLab device have shown that a tear osmolarity value over 306mOsm/l is considered a already so elevated that it indicates a Dry Eye condition. Increasing clinical severity of Dry Eye Disease was reported to correlate with increasing Osmolarity values by Piera VERSURA and colleagues and by many other researches. The close correlation of tear osmolarity with the clinical severity of Eye Disease becomes understandable by the strongly irritant effect of hyper-osmolar stress on the ocular surface epithelium as described above.